Partnership & Research

Partnership & Research
Partnerships & Research

Advancing Innovation Through Collaboration

Cyclotek partners with researchers, healthcare providers, universities, and pharmaceutical organisations to support scientific discovery, clinical innovation, and the development of next-generation molecular imaging solutions.

For over two decades, Cyclotek has supported research programs, clinical studies, and scientific collaborations that advance healthcare outcomes and molecular imaging capabilities.

Through collaboration, innovation, and technical expertise, Cyclotek contributes to research initiatives that improve diagnostic capabilities and advance patient care.

Our Approach to Innovation

Translating Radiopharmaceutical Innovation into Patient Access 

The healthcare sector is entering an era of more personalised medicine, where accurate biological imaging can help clinicians better understand disease and treatment response. Cyclotek’s R&D role is to help bridge the gap between promising radiopharmaceutical science and practical clinical access through manufacturing capability, quality systems, regulatory experience and clinical trial support.

Our Partnerships

Our Research & Industry Network

Cyclotek collaborates with leading universities, research institutes, pharmaceutical innovators, and clinical partners to advance molecular imaging and radiopharmaceutical development. These partnerships support research, clinical translation, technology transfer, and improved patient outcomes across the region.

Universities

Supporting the next generation of research through academic collaboration and scientific innovation.

Research Institutions

Working alongside world-class research organisations to accelerate discovery and translational science.

Pharmaceutical Partners

Collaborating with pharmaceutical companies to develop and commercialise advanced radiopharmaceutical solutions.

Research Collaborations

Research Partnerships and Collaborations 

Cyclotek works with academic institutions, hospital research units and biotechnology companies to bring novel tracers into clinical investigation and practical use across Australia and New Zealand. Cyclotek applies formal qualification and validation activities to confirm that equipment, processes and control systems perform as intended before routine production. Ongoing review and re-validation support continued performance, particularly after system changes, upgrades or regulatory requirements. 

  • University of Melbourne

    Research collaboration focused on novel radiopharmaceutical development and clinical translation. 

  • Monash University

    Research and supply collaboration supporting novel imaging applications. 

  • Princess Alexandra Hospital

    Investigator-sponsored study support for novel clinical applications of PET imaging.